PRESS RELEASES

Date Title View
Toggle Summary Chimerix Announces Martha J. Demski as Board Chair; Appoints New Members to Board of Directors
DURHAM, N.C. , March 29, 2018 (GLOBE NEWSWIRE) -- Chimerix  (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced the appointment of Martha J. Demski as Chair of the Board of Directors. Martha will succeed Ernest Mario , PhD, who is
View HTML
Toggle Summary The AdVance Study: a Landmark Natural History Study of Adenovirus in Allogeneic Hematopoietic Cell Transplant Shows Strong Correlation Between Disease Burden and Mortality Risk
European, multi-center study reinforces need for effective therapies for adenovirus in immunocompromised patients DURHAM, N.C. , March 19, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced data
View HTML
Toggle Summary Chimerix to Present at Cowen and Company 38th Annual Health Care Conference
DURHAM, N.C. , March 07, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that M. Michelle Berrey , M.D., M.P.H, President and Chief Executive Officer of Chimerix, will
View HTML
Toggle Summary Chimerix Announces Fourth Quarter and Full Year 2017 Financial Results
- AdVance Data to be Presented at EBMT Annual Meeting - - Oral and IV BCV Programs Remain on Track -   - Conference Call at 8:30 a.m. ET Today - DURHAM, N.C. , March 01, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical
View HTML
Toggle Summary Chimerix to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018
DURHAM, N.C. , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that it will host a live conference call and audio webcast on Thursday, March 1, 2018 at
View HTML
Toggle Summary Chimerix Initiates AdAPT Study for Oral Brincidofovir and Advances IV Brincidofovir to Patient Studies
- Pivotal AdAPT Study of Oral Brincidofovir for Adenovirus Now Enrolling -  - No GI Adverse Effects for IV Brincidofovir 10 mg - - Announces First Antiviral Specific for Norovirus Now In Clinical Testing - DURHAM, N.C. , Jan. 05, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical
View HTML
Toggle Summary Chimerix to Present at the 36th Annual J.P. Morgan Healthcare Conference
DURHAM, N.C. , Jan. 03, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to provide solutions to the growing population of immunocompromised patients, today announced that M. Michelle Berrey , M.D., M.P.H, President and Chief Executive Officer
View HTML
Toggle Summary Chimerix Announces Third Quarter 2017 Financial Results
Conference Call at 8:30 a.m. ET Today DURHAM, N.C. , Nov. 08, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today reported financial results and provided a  corporate  update  for  the  third  quarter
View HTML
Toggle Summary Chimerix to Present at the Stifel 2017 Healthcare Conference
DURHAM, N.C. , Nov. 07, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey , M.D., M.P.H., Chief Executive Officer of Chimerix and Garrett Nichols , M.D., M.S., Chief
View HTML
Toggle Summary Chimerix to Announce Third Quarter 2017 Financial Results on November 8, 2017
DURHAM, N.C. , Nov. 01, 2017 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients, today announced that it will host a live conference call and audio webcast on
View HTML